 |
Strongbridge Biopharma plc
SBBP
|
-37.22 |
- |
1.52 % |
$ 136 M |
USA |
 |
Seneca Biopharma, Inc.
SNCA
|
-124.66 |
- |
-1.19 % |
$ 28.7 M |
USA |
 |
Celsion Corporation
CLSN
|
117.96 |
- |
-6.63 % |
$ 13.9 M |
USA |
 |
I-Mab
IMAB
|
-56.09 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
23.87 |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
-142.36 |
- |
-13.47 % |
$ 169 M |
France |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-40.14 |
- |
0.74 % |
$ 768 M |
Israel |
 |
Abcam plc
ABCM
|
-0.8 |
- |
- |
$ 4.9 B |
Britain |
 |
Midatech Pharma plc
MTP
|
-35.12 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
MorphoSys AG
MOR
|
-9.36 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Affimed N.V.
AFMD
|
-109.04 |
- |
-34.95 % |
$ 21.5 M |
Germany |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-251.78 |
- |
-1.58 % |
$ 28.1 M |
China |
 |
Celyad Oncology SA
CYAD
|
-207.62 |
- |
- |
$ 12.5 M |
Belgium |
 |
Gracell Biotechnologies
GRCL
|
-36.68 |
- |
- |
$ 3.37 B |
China |
 |
Galapagos NV
GLPG
|
9.42 |
- |
- |
$ 1.83 B |
Belgium |
 |
Teligent, Inc.
TLGT
|
-12.14 |
- |
-13.85 % |
$ 16.1 M |
USA |
 |
Viela Bio, Inc.
VIE
|
-35.6 |
- |
- |
$ 2.91 B |
USA |
 |
Aphria Inc.
APHA
|
-3.39 |
- |
-0.45 % |
$ 4.87 B |
Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
-9.61 |
- |
-0.90 % |
$ 104 M |
USA |
 |
Chiasma, Inc.
CHMA
|
-42.41 |
- |
-6.00 % |
$ 238 M |
USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-47.82 |
- |
- |
$ 376 M |
USA |
 |
Cellect Biotechnology Ltd.
APOP
|
78.84 |
- |
0.38 % |
$ 12.9 M |
Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
-252799694827.9 |
- |
2.07 % |
$ 34.4 M |
USA |
 |
Cerecor Inc.
CERC
|
-145.12 |
- |
-1.68 % |
$ 283 M |
USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
-28.6 |
- |
- |
$ 1.63 B |
USA |
 |
Auris Medical Holding Ltd.
EARS
|
-39.43 |
- |
-1.77 % |
$ 39.2 M |
Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
-15.93 |
- |
0.34 % |
$ 2.98 B |
USA |
 |
ERYTECH Pharma S.A.
ERYP
|
-0.5 |
- |
1.3 % |
$ 27.7 M |
France |
 |
GW Pharmaceuticals plc
GWPH
|
-6.19 |
- |
- |
$ 6.81 B |
Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
-66.94 |
- |
- |
$ 1.7 B |
USA |
 |
Liminal BioSciences
LMNL
|
1.23 |
- |
- |
$ 256 M |
Canada |
 |
Neos Therapeutics, Inc.
NEOS
|
-18.6 |
- |
-2.54 % |
$ 57.2 M |
USA |
 |
Odonate Therapeutics, Inc.
ODT
|
-75.26 |
- |
-3.18 % |
$ 58.5 M |
USA |
 |
Orphazyme A/S
ORPH
|
-76.99 |
- |
-2.25 % |
$ 31.3 M |
Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
-21.46 |
- |
-10.74 % |
$ 89.9 M |
USA |
 |
Pandion Therapeutics, Inc.
PAND
|
-16722.69 |
- |
- |
$ 1.77 B |
USA |
 |
Translate Bio, Inc.
TBIO
|
-6.04 |
- |
- |
$ 2.81 B |
USA |
 |
Trillium Therapeutics Inc.
TRIL
|
-19.73 |
- |
- |
$ 1.94 B |
Canada |
 |
Urovant Sciences Ltd.
UROV
|
-231.84 |
- |
- |
$ 532 M |
Britain |
 |
Acceleron Pharma Inc.
XLRN
|
-13.39 |
- |
- |
$ 10.9 B |
USA |
 |
Zealand Pharma A/S
ZEAL
|
-49.24 |
- |
0.52 % |
$ 821 M |
Danmark |
 |
Zogenix, Inc.
ZGNX
|
-32.16 |
- |
-4.97 % |
$ 664 M |
USA |
 |
Yunhong International
ZGYH
|
-1.14 |
- |
0.10 % |
$ 92.2 M |
China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
-54.65 |
- |
-7.58 % |
$ 264 M |
USA |
 |
Leap Therapeutics
LPTX
|
3.06 |
- |
368.57 % |
$ 41.9 M |
USA |
 |
Cortexyme
CRTX
|
-89.8 |
- |
-1.05 % |
$ 67.1 M |
USA |
 |
Aptorum Group Limited
APM
|
-7.29 |
- |
- |
$ 5.72 M |
China |